Please login to the form below

Not currently logged in
Email:
Password:

European biotech

This page shows the latest European biotech news and features for those working in and with pharma, biotech and healthcare.

Encouraging data for GenSight’s blinding retinal disease gene therapy

Encouraging data for GenSight’s blinding retinal disease gene therapy

Luxturna, was the first ever gene therapy to be approved for any form of genetic blindness in the US, and now it’s edging closer to that all important European approval. ... UK biotech startup Nightstar is also making waves in this space, bagging a fast

Latest news

More from news
Approximately 8 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • European venture funding for the life science sector European venture funding for the life science sector

    Capital markets infrastructure is a barrier. European biotech companies continue to find it hard to raise public money in Europe. ... Pockets of success on Euronext mask the fact that leading European venture groups primarily look to the Nasdaq, at least

  • European sites European sites

    very large European life science industry offers a fertile ground for investments, collaboration and acquisitions. ... Key findings. In total there are roughly 11, 000 life science companies (biotech, pharma, medtech) across 14 European countries and in

  • Pharma deals in March 2015 Pharma deals in March 2015

    One of Bavarian Nordic's sites is in Martinsried, the biotech cluster near Munich. ... The Morphosys story highlights the uncertainty of funding for European biotech companies.

  • Pharma deals during December 2012 Pharma deals during December 2012

    Another deal involving European biotech companies is the acquisition of the Austrian company Intercell by Vivalis based in France for an all share deal valued at $174m. ... Both companies are loss making. It is billed as “a merger of equals”, with

  • Interview with Andrea Rappagliosi, EuropaBio Interview with Andrea Rappagliosi, EuropaBio

    The current financial crisis exacerbates the task. I think that in the wider context of the pharmaceutical industry, the European biotech industry can definitely play a role in boosting investment in ... From a biotech perspective, the proposed single

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics